-
Tauroursodeoxycholic Acid CAS 14605 22 2Tauroursodeoxycholic Acid CAS 14605-22-2, is a naturally occurring hydrophilic tertiary bile acid, a combination of ursodeoxycholic acid (UDCA) and taurine.read more
Indications: It dissolves... -
Ciprofibrate CAS 52214-84-3Ciprofibrate CAS 52214-84-3, is a fibric acid derivative (fibrate) used for the treatment of hyperlipidemia (elevated blood lipids). It belongs to the class of peroxisome proliferator-activated...read more
-
Esmolol Hcl CAS 861161-17-3Esmolol HCl CAS 861161-17-3, is an ultra-short-acting, cardioselective beta-adrenergic antagonist (beta-blocker) used primarily for the rapid control of heart rate and blood pressure in acute...read more
-
Fenofibrate CAS 49562-28-9Fenofibrate CAS 49562-28-9, is a fibric acid derivative (fibrate) used for the treatment of hyperlipidemia (elevated blood lipids). It is a peroxisome proliferator-activated receptor alpha (PPARα)...read more
-
Eltrombopag Olamine CAS 496775-62-3Eltrombopag Olamine CAS 496775-62-3, is a thrombopoietin receptor agonist (TPO-RA) that stimulates the production of platelets. It is a small-molecule, non-peptide agonist that mimics the action...read more
-
Tofacitinib Citrate CAS 540737-29-9Tofacitinib Citrate CAS 540737-29-9, is a Janus kinase (JAK) inhibitor that is administered orally and has immunomodulatory and anti-inflammatory effects. It is a citrate formed by combining...read more
-
Delgocitinib CAS 1263774-59-9Delgocitinib CAS 1263774-59-9, is a topical Janus kinase (JAK) inhibitor. As the world's first approved topical JAK inhibitor for the treatment of skin diseases, it provides a new treatment option...read more
-
Lemborexant CAS 1369764-02-2Lemborexant CAS 1369764-02-2, is a Sleep Initiation and Maintenance Disorders drug used for treatment of adult insomnia characterized by difficulty falling asleep and/or maintaining sleep.read more
-
Trelagliptin Succinate CAS 1029877-94-8Trelagliptin Succinate CAS 1029877-94-8, is a dipeptidyl peptidase-4 (DPP-4) inhibitor, treatment of Type 2 Diabetes.read more
Tauroursodeoxycholic acid | C26H45NO6S | CID 9848818 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities,...
Tauroursodeoxycholic acid, also known as ursodoxicoltaurine, is a highly hydrophilic tertiary bile acid 3 that is produced in humans at a low concentration. 3 It is a taurine conjugate of...
In recent years, hydrophilic bile acids, particularly tauroursodeoxycholic acid (TUDCA), have shown important anti-apoptotic and neuroprotective activities, with numerous experimental and...
Tauroursodeoxycholic Acid TUDCA is a water soluble bile acid. It shows great potency in treating cholestasis (bile acid backup in the liver) as the water soluble bile acids counteract the...
Source: Restorative Medicine Digest. October 19, 2021. Tauroursodeoxycholic acid (TUDCA) is a hydrophilic bile acid synthesized in hepatocytes by the conjugation of ursodeoxycholic...
Tauroursodeoxycholic acid (TUDCA) is the taurine conjugate of ursodeoxycholic acid (UDCA), a US Food and Drug Administration-approved hydrophilic bile acid for the...
